The evidence base of complementary and alternative therapies in depression

Journal of Affective Disorders

Volumn 97, Issue 1-3, 2007, Pages 23-35

  Thachil, A F ^a   Mohan, R ^a   Bhugra, D ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

CAM; Complementary therapy; Depression; Depressive disorders; Evidence; Hierarchy of evidence

Indexed keywords

5 HYDROXYTRYPTOPHAN; ANTIDEPRESSANT AGENT; CROCUS SATIVUS EXTRACT; DOCOSAHEXAENOIC ACID; FLUOXETINE; FOLIC ACID; HYPERICUM EXTRACT; IMIPRAMINE; INOSITOL; LAVANDULA ANGUSTIFOLIA EXTRACT; PASSION FLOWER EXTRACT; PLACEBO; PLANT EXTRACT; S ADENOSYLMETHIONINE; SEROTONIN UPTAKE INHIBITOR; TETRACYCLIC ANTIDEPRESSANT AGENT; TRAZODONE; TRYPTOPHAN; TYROSINE; VALERIAN;

ACUPUNCTURE; ADD ON THERAPY; ALTERNATIVE MEDICINE; AROMATHERAPY; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; DEPRESSION; DRUG EFFICACY; DRUG WITHDRAWAL; EVIDENCE BASED MEDICINE; EXERCISE; HERBAL MEDICINE; HOMEOPATHY; HUMAN; HYPERICUM PERFORATUM; INFORMATION RETRIEVAL; LAVENDER; MAJOR DEPRESSION; MEDICINAL PLANT; MONOTHERAPY; MOVEMENT THERAPY; MUSIC THERAPY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RELAXATION TRAINING; REVIEW; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; YOGA;

COMPLEMENTARY THERAPIES; DEPRESSIVE DISORDER; EVIDENCE-BASED MEDICINE; HUMANS; PHYTOTHERAPY; RANDOMIZED CONTROLLED TRIALS;

EID: 33845685607     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jad.2006.06.021     Document Type: Review

References (50)

1. Akhondzadeh S., Kashani L., Fotouhi A., Jarvandi S., Mobaseri M., Moin M., Khani M., Jamshidi A.H., Baghalian K., and Taghizadeh M. Comparison of Lavandula angustifolia Mill. Tincture and Imipramine in the treatment of mild to moderate depression: a double-blind, randomized trial. Prog. Neuro-psychopharmacol. Biol. Psychiatry 27 1 (2003) 123-127
2. Akhondzadeh S., Fallah-Pour H., Afkham K., Jamshidi A.H., and Khalighi-Cigaroudi F. Comparison of Crocus sativus L. and imipramine in the treatment of mild to moderate depression: a pilot double-blind randomized trial. BMC Complement. Altern. Med. 4 (2004) 12
3. Astin J.A. Why patients use alternative medicine: results of a national study. JAMA 279 (1998) 1548-1553
4. Bressa G.M. S-adenosyl-l-methionine (SAMe) as antidepressant: meta-analysis of clinical studies. Acta Neurol. Scand., Suppl. 154 (1994) 7-14
5. Campbell M., Fitzpatrick R., Haines A., Kinmonth A.L., Sandercock P., Spiegelhalter D., et al. Framework for design and evaluation of complex interventions to improve health. BMJ 321 (2000) 694-696
6. Canter P.H., Coon J.T., and Ernst E. Cost effectiveness of complementary treatments in the United Kingdom: systematic review. BMJ 331 (2005) 880-881
7. Cooper B. Evidence-based mental health policy: a critical appraisal. Br. J. Psychiatry 183 (2003) 105-113
8. Davidson J.R.T., and Meltzer-Brody S.E. The under-recognition and under-treatment of depression: what is the breadth and depth of the problem?. J. Clin. Psychiatry 60 suppl 7 (1999) 4-9
9. Department of Health. National Service Framework for Mental Health: Modern Standards and Service Models (1999), Department of Health, London
10. Ernst E., et al. The Desktop Guide to Complementary and Alternative Medicine-An Evidence-Based Approach (2001), Mosby
11. Ernst E., and White A.R. The BBC survey of complementary medicine use in the UK. Complement. Ther. Med. 8 (2000) 32-36
12. Fabrega H. Medical validity in Eastern and Western traditions. Perspect. Biol. Med. 45 (2002) 395-415
13. Gelenberg A.J., Wojcik J.D., Falk W.E., and Baldessarini R.J. Tyrosine for depression: a double-blind trial. J. Affect. Disord. 19 2 (1990) 125-132
14. Government Response to The House of Lords Select Committee on Science and Technology's Report on Complementary and Alternative Medicine. Presented to Parliament by the Secretary of State for Health By command of Her Majesty. Department of Health 2001, March. © Crown Copyright 2001.
15. Gray Muir J.A. Evidence based Healthcare: how to make health policy and management decisions (1997), Churchill Livingstone, New York 61
16. Hanser S.B., and Thompson L.W. Effects of music therapy strategy on depressed older adults. J. Gerontol. 49 (1994) 265-269
17. House of Lords Select Committee on Science and Technology Complementary and Alternative Medicine. 6th Report 1999-2000 (2000), Stationery Office, London
18. Janakiramiah N., Gangadhar B.N., Naga Venkatesha Murthy P.J., Harish M.G., Subbakrishna D.K., and Vedamurthachar A. Antidepressant efficacy of Sudarshan Kriya Yoga (SKY) in melancholia: a randomised comparison with electroconvulsive therapy (ECT) and imipramine. J. Affect. Disord. 57 1-3 (2000) 255-259
19. Jonas W.B. The evidence house: how to build an inclusive base for complementary medicine. West. J. Med. 175 (2001) 79-80
20. Kendrick T. Why can't GPs follow guidelines on depression?. BMJ 320 (2000) 200-201
21. Kessler R.C., Soukup J., Davis R.B., Foster D.F., Wilkey S.A., Van Rompay M.I., and Eisenberg D.M. The use of complementary and alternative therapies to treat anxiety and depression in the United States. Am. J. Psychiatry 158 2 (2001) 289-294
22. Lawlor D.A., and Hopker S.W. The effectiveness of exercise as an intervention in the management of depression: systematic review and meta-regression analysis of randomised controlled trials. BMJ 322 (2001) 1-8
23. Linde K., Jonas W.B., Melchart D., and Willich S. The methodological quality of randomized controlled trials of homeopathy, herbal medicines and acupuncture. Int. J. Epidemiol. 30 (2001) 526-531
24. Linde K, Mulrow C.D., Berner, M., Egger, M. St John's Wort for depression. The Cochrane Database of Systematic Reviews 2005, Issue 3. Art. No.: CD000448. doi:10.1002/14651858.CD000448.pub2.
25. MacLennan A.H., Wilson D.H., and Taylor A.W. Prevalence and cost of alternative medicine in Australia. Lancet 347 (1996) 569-573
26. Manheimer E., Berman B., Dubnick H., and Beckner W. Cochrane Reviews of Complementary and Alternative Therapies: Evaluating the Strength of the Evidence (2004). http://www.cochrane.org/colloquia/abstracts/ottawa/P-094.htm www.cochrane.org/colloquia/abstracts/ottawa/P-094.htm (accessed 10 Oct 2005)
27. Marangell L.B., Martinez J.M., Zboyan H.A., Kertz B., Kim H.F., and Puryear L.J. A double blind, placebo-controlled study of the omega-3 fatty acid docosahexaenoic acid in the treatment of major depression. Am. J. Psychiatry 160 5 (2003) 996-998
28. Micozzi M.S. Fundamentals of Complementary and Alternative Medicine. 3rd edition (2005), Elsevier, New York
29. Moncrieff, J., Wessely, S., Hardy, R. Active placebos versus antidepressants for depression. The Cochrane Database of Systematic Reviews 2004, Issue 1. Art. No.: CD003012. doi:10.1002/14651858.CD003012.pub2.
30. MRC. A framework for development and evaluation of RCTs for complex interventions to improve health (2000)
31. Murphy G.E., Carney R.M., Knesevich M.A., Wetzel R.D., and Whitworth P. CBT, relaxation training and TCA medication in the treatment of depression. Psychol. Rep. 77 (1995) 403-420
32. Noorbala A.A., Akhondzadeh S., Tahmacebi-Pour N., and Jamshidi A.H. Hydro-alcoholic extract of Crocus sativus L. versus fluoxetine in the treatment of mild to moderate depression: a double-blind, randomized pilot trial. J. Ethnopharmacol. 97 2 (2005) 281-284
33. Okamoto A., Kuriyama H., Watanabe S., Aihara Y., Tadai T., Imanishi J., and Fukui K. The effect of aromatherapy massage on mild depression: a pilot study. Psychiatry Clin. Neurosci. 59 3 (2005) 363
34. Raben H., and Aggernaes K.H. Psykiatriske patienters brug af alternativ behandling. Ugeskr. Laeger 153 (1991) 782-784
35. Razali S.M., and Najib M.A. Help seeking pathways among Malay psychiatric patients. Int. J. Soc. Psychiatry 46 4 (2000) 281-289
36. Scott J., and Dickey B. Global burden of depression: the intersection of culture and medicine. Br. J. Psychiatry 183 (2003) 92-94
37. Shaw, K., Turner, J., Del Mar, C. Tryptophan and 5-Hydroxytryptophan for depression. The Cochrane Database of Systematic Reviews 2002, Issue 1. Art. No.: CD003198. doi:10.1002/14651858.CD003198.
38. Smith, C.A., Hay, P.P.J. Acupuncture for depression. The Cochrane Database of Systematic Reviews 2004, Issue 3. Art. No.: CD004046. doi:10.1002/14651858.CD004046.pub2.
39. Stewart N.J., McMullen L.M., and Rubin L.D. Movement therapy with depressed inpatients: a randomized multiple single case-design. Arch. Psychiatr. Nurs. 8 (1994) 22-29
40. Taylor, M.J., Carney, S., Geddes, J., Goodwin, G. Folate for depressive disorders. The Cochrane Database of Systematic Reviews 2003, Issue 2. Art. No.: CD003390. doi:10.1002/14651858.CD003390.
41. Taylor, M.J., Wilder, H., Bhagwagar, Z., Geddes, J. Inositol for depressive disorders. The Cochrane Database of Systematic Reviews 2004, Issue 1. Art. No.: CD004049. doi:10.1002/14651858.CD004049.pub2.
42. The World Health Report. Mental Health: new understanding, new hope (2001), World Health Organization, Geneva
43. Thomas K.J., Nicholl J.P., and Coleman P. Use and expenditure on complementary medicine in England: a population based survey. Complement. Ther. Med. 9 (2001) 2-11
44. Thompson T., and Feder G. Complementary therapies and the NHS. BMJ 331 (2005) 856-857
45. Urlea-Schön I., Wartenberg-Demand A., and McGregor G. Efficacy of a triple herbal preparation in mild depressive disorders: results of a randomised placebo-controlled trial. Focus Altern. Complement. Ther. 8 (2003) 551-552
46. Vickers A.J. Message to Complementary and Alternative Medicine: evidence is a better friend than power. BMC Complement. Altern. Med. 1 (2001) 1
47. Vickers A., Cassileth B., Ernst E., Fisher P., Goldman P., Jonas W., Kang S.K., Lewith G., Schulz K., and Silagy C. How should we research unconventional therapies? A panel report from the Conference on Complementary and Alternative Medicine Research Methodology. National Institutes of Health. Int. J. Technol. Assess. Health Care 13 (1997) 111-121
48. Walach H. The efficacy paradox in randomized controlled trials of CAM and elsewhere: beware of the placebo trap. J. Altern. Complement. Med. 7 (2001) 213-218
49. White P., Lewith G., Hopwood V., and Prescott P. The 'placebo' needle, is it a valid and convincing control for use in acupuncture trials?-A randomised, single blind, crossover pilot trial. Focus Altern. Complement. Ther. 8 (2003) 554-555
50. Wu J., An H., Li Y., and Duan L. TCM treatment with the modified Wendan Tang in 40 cases of melancholia. J. Tradit. Chin. Med. 19 4 (1999) 296-297